Table VIII.
Group | n | T1 | T2 | T3 | T4 | F | P-value |
---|---|---|---|---|---|---|---|
Control group | 62 | 0.65±0.29 | 1.12±0.35a | 1.43±0.45a,b | 1.71±0.61a–c | 65.489 | <0.001 |
Study group | 84 | 0.64±0.34 | 1.59±0.41a | 1.97±0.54a,b | 2.48±0.65a–c | 203.549 | <0.001 |
t value | – | 0.187 | 7.278 | 6.401 | 7.261 | – | – |
P-value | – | 0.852 | <0.001 | <0.001 | <0.001 | – | – |
Compared with T1
P<0.05 compared with T2
P<0.05 compared with T3
P<0.05. T1, three days before treatment; T2, one month after treatment; T3, two months after treatment; T4, six months after treatment.